Cargando…
Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies
Type 2 diabetes mellitus (T2DM) is associated with a high risk of complications, essentially macrovascular events. Surprisingly, the effect of improved glucose control on coronary and cerebrovascular complications and the target level of glycated hemoglobin (HbA(1c)) in this population remains quest...
Autores principales: | Meier, Matthias, Hummel, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773745/ https://www.ncbi.nlm.nih.gov/pubmed/19898642 |
Ejemplares similares
-
Moving toward genome-editing therapies for cardiovascular diseases
por: Musunuru, Kiran
Publicado: (2022) -
Diabetes mellitus and impaired glucose tolerance are underdiagnosed in
intensive care units
por: Ladeira, Renata Teixeira, et al.
Publicado: (2012) -
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
por: Ma, Cheng-Xu, et al.
Publicado: (2022) -
Evidence-Based Clinical Review on Cardiovascular Benefits of SGLT2 (Sodium-Glucose Co-Transporter Type 2) Inhibitors in Type 2 Diabetes Mellitus
por: Rehman, Saad U, et al.
Publicado: (2020) -
Glycemic Control, Preexisting Cardiovascular Disease, and Risk of Major Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: Systematic Review With Meta‐Analysis of Cardiovascular Outcome Trials and Intensive Glucose Control Trials
por: Giugliano, Dario, et al.
Publicado: (2019)